Skip to main content

Advertisement

Table 1 Clinical characteristics of the patients

From: Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas

Factor TCGA LUAD Training TCGA LUAD Validation TCGA COAD Training TCGA COAD Validation
Num. of patients 328 167 286 141
Age, years, mean (SD) 65.8 (10.2) 64.5 (9.6) 66.6 (12.8) 66.4 (13.5)
Median survivor follow-up, days 506.5 218.0 716.5 730.0
Female, num. (%) 169 (51.5) 97 (58.1) 151 (52.8) 52 (36.9)
Stage I, num. (%) 176 (53.7) 90 (54.0) 50 (17.5) 22 (15.6)
Stage II, num. (%) 77 (23.5) 39 (23.4) 101 (35.3) 62 (44.0)
Stage III, num. (%) 49 (14.9) 31 (18.6) 75 (26.2) 44 (31.2)
Stage IV, num. (%) 21 (6.4) 5 (3.0) 50 (17.5) 12 (8.5)